ABC | Volume 115, Nº2, August 2020

Original Article Jardim et al. Real-world team-based care for HTN Arq Bras Cardiol. 2020; 115(2):174-181 8. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441- 50. 9. Proia KK, Thota AB, Njie GJ, Finnie RK, Hopkins DP, Mukhtar Q, et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47(1):86-99. 10. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based careinterventionsforhypertension.ArchInternMed.2009;169(19):1748-55. 11. Malachias MVB, Franco RJ, Forjaz CLM, Pierin AMG, Gowdak MMG, Klein MRST,etal.7thBrazilianGuidelineofArterialHypertension:chapter6-non- pharmacological treatment. Arq Bras Cardiol. 2016;107(3 supl 3):30-4. 12. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, et al. Hypertension Canada’s 2016 Canadian Hypertension Education ProgramGuidelines for Blood Pressure Measurement, Diagnosis, AssessmentofRisk,Prevention,andTreatmentofHypertension.CanJCardiol. 2016;32(5):569-88. 13. Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB. 7th Brazilian Guideline of Arterial Hypertension: chapter 2 - diagnosis and classification. Arq Bras Cardiol. 2016;107(3 supl 3):7-13. 14. Pereira DA, Costa NMSC, Sousa ALL, Jardim PCBV, Zanini CRO. The effect of educational intervention on the disease knowledge of diabetes mellitus patients. Rev Latino-Am Enfermagem. 2012;20(3):478-85. 15. Sousa AL, Jardim PC, Monego ET, Raimundo MS, Lopes KE, Coelho J, et al. Multidisciplinaryexperience intheapproachtothehypertensivepatient.Arq Bras Cardiol. 1992;59(1):31-5. 16. Jardim LM, Jardim TV, Souza WK, Pimenta CD, Sousa AL, Jardim PC. Multiprofessional treatment of high blood pressure in very elderly patients. Arq Bras Cardiol. 2017;108(1):53-9. 17. Jardim TV, Inuzuka S, Galvão L, Negretto LAF, Oliveira RO, Sá WF, et al. Multidisciplinary treatment of patients with diabetes and hypertension: experience of a Brazilian center. Diabetes Metab Syndr. 2018;10(3):1-8. 18. Milech A, Angelucci AP, Golbert A, Matheus A, Carrilho AJF, Ramalho AC, et al.DiretrizesdaSociedadeBrasileiradeDiabetes2015-2016.SãoPaulo:A.C. Farmacêutica; 2016. 19. Malachias MVB, Amodeo C, Paula RB, Cordeiro Jr AC, Magalhães LBNC, Bodanese LC. 7th Brazilian Guideline of Arterial Hypertension: Chapter 8 - hypertension and associated clinical conditions. Arq. Bras. Cardiol. 2016;107(3 supl 3):44-8. 20. LopesRD,BarrosoWKS,BrandaoAA,BarbosaECD,MalachiasMVB,Gomes MM, et al. The First Brazilian Registry of Hypertension. Am Heart J. 2018 Nov;205:154-7. 21. PinhoNA, Pierin AMG. Hypertension control in brazilian publications. Arq. Bras. Cardiol. 2013;101(3):e65-e73. 22. Jardim TV, Reiger S, Abrahams-Gessel S, Gomez-Olive FX, Wagner RG, Wade A, et al. Hypertensionmanagement in a population of older adults in rural South Africa. J Hypertens. 2017;35(6):1283-9. 23. Folb N, Timmerman V, Levitt NS, Steyn K, Bachmann MO, Lund C, et al. Multimorbidity, control and treatment of noncommunicable diseases among primary healthcare attenders in the Western Cape, South Africa. S Afr Med J. 2015;105(8):642-7. 24. GillespieCD, Hurvitz KA, Centers for DiseaseControl and Prevention (CDC). Prevalence of hypertension and controlled hypertension - United States, 2007-2010. MMWR Suppl. 2013;62(3):144-8. 25. Grossman A, Grossman E. Blood pressure control in type 2 diabetic patients. Cardiovasc Diabetol. 2017;16(1):3. 26. Krieger EM, Drager LF, Giorgi DMA, Pereira AC, Barreto-Filho JAS, Nogueira AR, et al. Spironolactone versus clonidine as a fourth-drug therapy for resistant hypertension: the ReHOT randomized study (Resistant Hypertension Optimal Treatment). Hypertension. 2018;71(4):681-90. 27. Wang H, Zhang X, Zhang J, He Q, Hu R, Wang L, et al. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in southern China: a community-based, cross-sectional survey. PLoS One. 2013;8(5):e62469. 28. Tipton AJ, Sullivan JC. Sex differences in blood pressure control: are T lymphocytes the missing link? Hypertension. 2014;64(2):237-9. 29. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323(7308):334-6. 30. Stanley K. Design of randomized controlled trials. Circulation. 2007;115(9):1164-9. 31. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation. 2008;118(12):1294-303. 32. Jacob V, Chattopadhyay SK, Thota AB, Proia KK, Njie G, Hopkins DP, et al. Economics of team-based care in controlling blood pressure: a Community Guide Systematic Review. Am J Prev Med. 2015;49(5):772-83. 33. Sousa AC, Jardim TV, Costa TO, Magalhães FG, Montelo MPM, Souza WKB, et al. Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years. Diabetol Metab Syndr. 2017;9:98. 34. BarrosoWKS, JardimPCB, JardimTSV, Souza CTS, Magalhães ALA, Ibrahim FM, et al. Hypertensive diabetic patients: guidelines for conduct and their difficulties. Arq Bras Cardiol. 2003;81(2):143-7. 180